Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women.

Ermel A, Tonui P, Titus M, Tong Y, Wong N, Ong'echa J, Muthoka K, Kiptoo S, Moormann A, Hogan J, Mwangi A, Cu-Uvin S, Loehrer PJ, Orang'o O, Brown D.

BMC Infect Dis. 2019 Apr 27;19(1):352. doi: 10.1186/s12879-019-3982-7.

2.

Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1.

Cespedes MS, Kang M, Kojic EM, Umbleja T, Godfrey C, Webster-Cyriaque JY, Masih R, Firnhaber C, Grinsztejn B, Saah A, Cu-Uvin S, Aberg JA.

Papillomavirus Res. 2018 Dec;6:15-21. doi: 10.1016/j.pvr.2018.08.002. Epub 2018 Aug 16.

3.

Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy.

Stringer EM, Kendall MA, Lockman S, Campbell TB, Nielsen-Saines K, Sawe F, Cu-Uvin S, Wu X, Currier JS.

PLoS One. 2018 Jul 18;13(7):e0199555. doi: 10.1371/journal.pone.0199555. eCollection 2018.

4.

High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy.

Saravanan S, Gomathi S, Delong A, Kausalya B, Sivamalar S, Poongulali S, Brooks K, Kumarasamy N, Balakrishnan P, Solomon SS, Cu-Uvin S, Kantor R.

J Antimicrob Chemother. 2018 Aug 1;73(8):2152-2161. doi: 10.1093/jac/dky154.

PMID:
29800305
5.

Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study.

Kojic EM, Conley L, Bush T, Cu-Uvin S, Unger ER, Henry K, Hammer J, Escota G, Darragh TM, Palefsky JM, Brooks JT, Patel P.

J Infect Dis. 2018 Apr 23;217(10):1544-1552. doi: 10.1093/infdis/jiy087.

PMID:
29452366
6.

Strategies for improving the lives of US women aged 40 and above living with HIV/AIDS: an evidence map.

Adam GP, Di M, Cu-Uvin S, Halladay C, Smith BT, Iyer S, Trikalinos TA.

Syst Rev. 2018 Feb 2;7(1):25. doi: 10.1186/s13643-018-0684-y.

7.

Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.

Omenge Orang'o E, Liu T, Christoffersen-Deb A, Itsura P, Oguda J, Washington S, Chumba D, Pisharodi L, Cu-Uvin S, Rositch AF.

AIDS. 2017 Jan 14;31(2):233-240. doi: 10.1097/QAD.0000000000001327.

8.

Strategies for Improving the Lives of Women Aged 40 and Above Living With HIV/AIDS [Internet].

Adam GP, Di M, Cu-Uvin S, Halladay C, Smith BT, Trikalinos TA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Nov.

9.

Reduced Levels and Bioactivity of Endogenous Protease Cathepsin D in Genital Tract Secretions of Postmenopausal Women.

Jais M, Younes N, Chapman S, Cu-Uvin S, Ghosh M.

AIDS Res Hum Retroviruses. 2017 May;33(5):407-409. doi: 10.1089/AID.2016.0240. Epub 2017 Jan 27. No abstract available.

10.

The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.

Hughes BL, Dutt R, Raker C, Barthelemy M, Rossoll RM, Ramratnam B, Wira CR, Cu-Uvin S.

Am J Obstet Gynecol. 2016 Dec;215(6):748.e1-748.e12. doi: 10.1016/j.ajog.2016.06.057. Epub 2016 Jul 5.

11.

Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature.

Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, Chapin KC, Kojic EM, Hardy EJ.

Infect Dis Obstet Gynecol. 2016;2016:5758387. doi: 10.1155/2016/5758387. Epub 2016 Jun 5. Review.

12.

Pregnancy Desire, Partner Serodiscordance, and Partner HIV Disclosure among Reproductive Age HIV-Infected Women in an Urban Clinic.

Rhodes CM, Cu-Uvin S, Rana AI.

Infect Dis Obstet Gynecol. 2016;2016:8048457. doi: 10.1155/2016/8048457. Epub 2016 May 26.

13.

HIV Exposure to the Epithelia in Ectocervical and Colon Tissues Induces Inflammatory Cytokines Without Tight Junction Disruption.

Sankapal S, Gupta P, Ratner D, Ding M, Shen C, Sanyal A, Stolz D, Cu-Uvin S, Ramratnam B, Chen Y.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1054-1066. Epub 2016 Jun 16.

14.

Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.

Jais M, Younes N, Chapman S, Cu-Uvin S, Ghosh M.

Am J Obstet Gynecol. 2016 Sep;215(3):324.e1-324.e10. doi: 10.1016/j.ajog.2016.03.041. Epub 2016 Mar 26.

PMID:
27026477
15.
16.

Human papillomavirus vaccination in HIV-infected women: need for increased coverage.

Kojic EM, Rana AI, Cu-Uvin S.

Expert Rev Vaccines. 2016;15(1):105-17. doi: 10.1586/14760584.2016.1110025. Epub 2015 Nov 24. Review.

17.

An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa.

Coleman JS, Cespedes MS, Cu-Uvin S, Kosgei RJ, Maloba M, Anderson J, Wilkin T, Jaquet A, Bohlius J, Anastos K, Wools-Kaloustian K.

J Low Genit Tract Dis. 2016 Jan;20(1):31-7. doi: 10.1097/LGT.0000000000000165.

18.

Assessment of Prevention of Mother-to-Child Transmission HIV Services in the Bantey Meanchey Province in Cambodia.

Sau MS, Balamane M, Lurie M, Harwell J, Welle E, Mean C, Cu-Uvin S.

J Int Assoc Provid AIDS Care. 2016 Jul;15(4):345-9. doi: 10.1177/2325957415599208. Epub 2015 Sep 3.

19.

Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral Therapy.

Conley LJ, Bush TJ, Darragh TM, Palefsky JM, Unger ER, Patel P, Steinau M, Kojic EM, Martin H, Overton ET, Cu-Uvin S, Hammer J, Henry K, Wood K, Brooks JT; SUN Study Group.

J Infect Dis. 2016 Feb 1;213(3):351-60. doi: 10.1093/infdis/jiv408. Epub 2015 Aug 12.

20.

Care of the HIV-infected pregnant woman in the developed world.

Hardy E, Cu-Uvin S.

Obstet Med. 2015 Mar;8(1):13-7. doi: 10.1177/1753495X14531753. Epub 2015 May 8. Review.

21.

Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS).

Sudenga SL, Wiener HW, King CC, Rompalo AM, Cu-Uvin S, Klein RS, Shah KV, Sobel JD, Jamieson DJ, Shrestha S.

PLoS One. 2014 Jun 11;9(6):e99109. doi: 10.1371/journal.pone.0099109. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e102728.

22.

Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research.

Venkatesh KK, Cu-Uvin S.

Am J Reprod Immunol. 2014 Jun;71(6):495-504. doi: 10.1111/aji.12247. Review.

PMID:
24832617
23.

Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.

Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, Saah A, Aberg JA, Cu-Uvin S.

Clin Infect Dis. 2014 Jul 1;59(1):127-35. doi: 10.1093/cid/ciu238. Epub 2014 Apr 9.

24.

HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077.

Kantor R, Bettendorf D, Bosch RJ, Mann M, Katzenstein D, Cu-Uvin S, D'Aquila R, Frenkel L, Fiscus S, Coombs R; ACTG A5077 Study Team.

PLoS One. 2014 Apr 3;9(4):e93537. doi: 10.1371/journal.pone.0093537. eCollection 2014.

25.

The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic.

Taylor LE, Foont JA, DeLong AK, Wurcel A, Linas BP, Chapman S, Maynard MA, Cu-Uvin S, Mayer KH.

AIDS Patient Care STDS. 2014 Jan;28(1):4-9. doi: 10.1089/apc.2013.0130.

26.

Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya.

Khozaim K, Orang'o E, Christoffersen-Deb A, Itsura P, Oguda J, Muliro H, Ndiema J, Mwangi G, Strother M, Cu-Uvin S, Rosen B, Washington S.

Int J Gynaecol Obstet. 2014 Jan;124(1):12-8. doi: 10.1016/j.ijgo.2013.06.035. Epub 2013 Sep 25.

PMID:
24140218
27.

Hepatocellular carcinoma in HIV-infected women: two case reports.

Westbrook ML, Garg S, Chapman S, Cu-Uvin S, Tashima KT, Taylor LE.

R I Med J (2013). 2013 Jan 4;96(1):21-4.

PMID:
23638454
28.

Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.

Fiscus SA, Cu-Uvin S, Eshete AT, Hughes MD, Bao Y, Hosseinipour M, Grinsztejn B, Badal-Faesen S, Dragavon J, Coombs RW, Braun K, Moran L, Hakim J, Flanigan T, Kumarasamy N, Campbell TB; A5185s Team.

Clin Infect Dis. 2013 Jul;57(2):290-7. doi: 10.1093/cid/cit195. Epub 2013 Mar 26.

29.

Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.

Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM, Cu-Uvin S.

J Womens Health (Larchmt). 2013 Apr;22(4):330-8. doi: 10.1089/jwh.2012.3849. Epub 2013 Mar 26.

30.

HIV and reproduction: fertility, contraception, and preconception issues and interventions.

Anderson JR, Cohan D, Cu-Uvin S.

Infect Dis Obstet Gynecol. 2012;2012:736864. doi: 10.1155/2012/736864. Epub 2012 Dec 30. No abstract available.

31.

Pregnancy-induced changes in immune protection of the genital tract: defining normal.

Anderson BL, Mendez-Figueroa H, Dahlke JD, Raker C, Hillier SL, Cu-Uvin S.

Am J Obstet Gynecol. 2013 Apr;208(4):321.e1-9. doi: 10.1016/j.ajog.2013.01.014. Epub 2013 Jan 10.

32.

Assessing the relationship between cervical ectopy and HIV susceptibility: implications for HIV prevention in women.

Venkatesh KK, Cu-Uvin S.

Am J Reprod Immunol. 2013 Feb;69 Suppl 1:68-73. doi: 10.1111/aji.12029. Epub 2012 Oct 11. Review.

PMID:
23057756
33.

Antiretrovirals and safer conception for HIV-serodiscordant couples.

Matthews LT, Smit JA, Cu-Uvin S, Cohan D.

Curr Opin HIV AIDS. 2012 Nov;7(6):569-78. doi: 10.1097/COH.0b013e328358bac9. Review. Erratum in: Curr Opin HIV AIDS. 2013 Jan;8(1):86.

34.

Effect of trichomoniasis therapy on genital HIV viral burden among African women.

Anderson BL, Firnhaber C, Liu T, Swarts A, Siminya M, Ingersoll J, Caliendo AM, Cu-Uvin S.

Sex Transm Dis. 2012 Aug;39(8):638-42. doi: 10.1097/OLQ.0b013e31825725ad.

35.

The changing face of HIV in pregnancy in Rhode Island 2004-2009.

Firth J, Wang CC, Gillani F, Alexander N, Dufort E, Rana A, Cu-Uvin S.

Infect Dis Obstet Gynecol. 2012;2012:895047. doi: 10.1155/2012/895047. Epub 2012 Jun 17.

36.

Acceptance of HIV Antibody Testing Among Women in Domestic Violence Shelters.

Ratcliff TM, Zlotnick C, Cu-Uvin S, Payne N, Sly K, Flanigan T.

J HIV AIDS Soc Serv. 2012 Jul 1;11(3):291-304.

37.

In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women.

Anderson BL, Ghosh M, Raker C, Fahey J, Song Y, Rouse DJ, Wira CR, Cu-Uvin S.

Am J Obstet Gynecol. 2012 Jul;207(1):65.e1-10. doi: 10.1016/j.ajog.2012.04.029. Epub 2012 Apr 30.

38.

Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.

Lahey T, Ghosh M, Fahey JV, Shen Z, Mukura LR, Song Y, Cu-Uvin S, Mayer KH, Wright PF, Kappes JC, Ochsenbauer C, Wira CR.

PLoS One. 2012;7(6):e38100. doi: 10.1371/journal.pone.0038100. Epub 2012 Jun 4.

39.

Infant outcomes after maternal antiretroviral exposure in resource-limited settings.

Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman KL, Shapiro DE, Mofenson L, Moran L, Campbell TB, Hitti J, Fiscus S, Currier J; ACTG 5190/PACTG 1054 Study Team.

Pediatrics. 2012 Jun;129(6):e1525-32. doi: 10.1542/peds.2011-2340. Epub 2012 May 14.

40.

Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz.

Carten ML, Kiser JJ, Kwara A, Mawhinney S, Cu-Uvin S.

Infect Dis Obstet Gynecol. 2012;2012:137192. doi: 10.1155/2012/137192. Epub 2012 Feb 28.

41.

Effect of HSV-2 suppressive therapy on genital tract HIV-1 RNA shedding among women on HAART: a pilot randomized controlled trial.

Nijhawan AE, Delong AK, Chapman S, Rana A, Kurpewski J, Ingersoll J, Caliendo AM, Cu-Uvin S.

Infect Dis Obstet Gynecol. 2012;2012:868526. doi: 10.1155/2012/868526. Epub 2012 Feb 28.

42.

Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.

Mukura LR, Ghosh M, Fahey JV, Cu-Uvin S, Wira CR.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1533-9. doi: 10.1089/AID.2011.0394. Epub 2012 Mar 23.

43.
44.

Association between semen exposure and incident bacterial vaginosis.

Gallo MF, Warner L, King CC, Sobel JD, Klein RS, Cu-Uvin S, Rompalo AM, Jamieson DJ.

Infect Dis Obstet Gynecol. 2011;2011:842652. doi: 10.1155/2011/842652. Epub 2011 Dec 8.

45.

Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya.

Mabeya H, Khozaim K, Liu T, Orango O, Chumba D, Pisharodi L, Carter J, Cu-Uvin S.

J Low Genit Tract Dis. 2012 Apr;16(2):92-7. doi: 10.1097/LGT.0b013e3182320f0c.

46.

The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women.

Nijhawan AE, DeLong AK, Celentano DD, Klein RS, Sobel JD, Jamieson DJ, Cu-Uvin S.

Sex Transm Dis. 2011 Dec;38(12):1094-100. doi: 10.1097/OLQ.0b013e31822ea147.

47.

Discordance between spermatozoa detection and self-reported semen exposure.

Gallo MF, Sobel JD, Rompalo AM, Cu-Uvin S, Schoenbaum E, Jamieson DJ.

Sex Transm Dis. 2011 Oct;38(10):909-12. doi: 10.1097/OLQ.0b013e318223be4b.

PMID:
21934562
48.

Bacterial vaginosis and the natural history of human papillomavirus.

King CC, Jamieson DJ, Wiener J, Cu-Uvin S, Klein RS, Rompalo AM, Shah KV, Sobel JD.

Infect Dis Obstet Gynecol. 2011;2011:319460. doi: 10.1155/2011/319460. Epub 2011 Aug 16.

49.

See-and-treat approaches to cervical cancer prevention for HIV-infected women.

Chibwesha CJ, Cu-Uvin S.

Curr HIV/AIDS Rep. 2011 Sep;8(3):192-9. doi: 10.1007/s11904-011-0084-6.

50.

Addition of Acyclovir does not affect Adherence to HAART in HIV-1/ HSV-2 Co-Infected Women.

Eleanya C, Delong A, Chapman S, Nijhawan A, Ingersoll J, Caliendo AM, Cu-Uvin S.

J AIDS Clin Res. 2010 Dec 22;1(4). pii: 1000113. No abstract available.

Supplemental Content

Loading ...
Support Center